Since the late 1800s, the field of immuno-oncology has been exploring the relationship between the immune system and the development, progression, and treatment of cancer.
From biomarker identification and epigenetic analysis, to tumor response and tumor immunogenicity determination, advances in genomic technologies, like next-generation sequencing, are helping advance our understanding of interactions between the immune system and cancer, guiding therapeutic development. To learn more please visit the Illumina website.
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?